HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
Authors
Keywords
-
Journal
Blood Advances
Volume 5, Issue 1, Pages 167-175
Publisher
American Society of Hematology
Online
2021-01-11
DOI
10.1182/bloodadvances.2020003353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study
- (2019) Radhika Gangaraju et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantation
- (2019) Radhika Gangaraju et al. CANCER
- Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis
- (2019) Ang Li et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism incidence in hematologic malignancies
- (2018) Natasha Kekre et al. BLOOD REVIEWS
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous thromboembolism is associated with graft- versus -host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
- (2017) Natasha Kekre et al. HAEMATOLOGICA
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
- (2017) Nick van Es et al. HAEMATOLOGICA
- Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort
- (2017) Damon E. Houghton et al. LEUKEMIA & LYMPHOMA
- Venous thromboembolism is associated with graft- versus -host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
- (2017) Natasha Kekre et al. HAEMATOLOGICA
- Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
- (2017) Nick van Es et al. HAEMATOLOGICA
- Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
- (2016) Darko Antic et al. AMERICAN JOURNAL OF HEMATOLOGY
- Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis
- (2016) Mohammad Faizan Zahid et al. ANNALS OF HEMATOLOGY
- Venous thromboembolism in hematopoietic stem cell transplant recipients
- (2015) S Chaturvedi et al. BONE MARROW TRANSPLANTATION
- Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
- (2012) J. Labrador et al. HAEMATOLOGICA
- The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
- (2008) D. E. Gerber et al. BLOOD
- Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation
- (2008) A. GONSALVES et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started